Recent Publications by PRA International: |
Theoretical models in LC based bioanalytical method development.
Bioanalytical method development largely depends on the experience and the... | 11th November, 2008
| PRA international, early development services, P.O. box 200, 9407AE
| J Pharm Biomed Anal. 2008 Oct 4.
DOI Direct Link |
Low hanging fruit in infectious disease drug development.
Cost estimates for developing new molecular entities (NME) are reaching... | 30th September, 2008
| Infectious Diseases Research Center, Scientific Affairs, PRA
| Curr Opin Microbiol. 2008 Oct;11(5):434-8. Epub 2008 Oct 15.
DOI Direct Link |
Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme.
The standard treatment for glioblastoma multiforme is surgery, radiation,... | 17th September, 2008
| Medical Director II Oncology, PRA International, Charlottesville, VA
| Technol Cancer Res Treat. 2008 Jun;7(3):241-8.
|
New practical algorithm for modelling analyte recovery in bioanalytical reversed phase and mixed-mode solid phase extraction.
Solid phase extraction (SPE) is a widely used method for sample cleanup... | 27th June, 2008
| PRA International, Early Development Services, P.O. Box 200, 9407AE
| J Pharm Biomed Anal. 2008 Sep 10;48(1):158-70. Epub 2008 May 17.
DOI Direct Link |
pH adjustment of human blood plasma prior to bioanalytical sample preparation.
pH adjustment in bioanalytical sample preparation concerning ionisable... | 19th January, 2008
| PRA International, Early Development Services, P.O. Box 200, 9407AE
| J Pharm Biomed Anal. 2008 May 12;47(1):126-33. Epub 2007 Dec 8.
DOI Direct Link |
Reconsideration of sample pH adjustment in bioanalytical liquid-liquid extraction of ionisable compounds.
Liquid-liquid extraction (LLE) is widely used as a simple and robust... | 31st August, 2007
| PRA International, EDS Services, P.O. Box 200, 9407AE Zuidlaren, The
| J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun
DOI Direct Link |
India's growing clinical research sector: opportunity for global companies.
Backed by a compelling foundation of essential requirements necessary for... | 24th August, 2007
| PRA International, Pacific House, Imperial Way, Reading, Berkshire, RG2
| IDrugs. 2007 Jun;10(6):391-4.
|
Endothelin receptor antagonists: clinical realities and future directions.
Endothelin (ET) is among the strongest endogenous vasoconstrictors known... | 4th May, 2005
| Global Product Development Services, PRA International, Mannheim, Germany.
| J Cardiovasc Pharmacol. 2005 Feb;45(2):182-91.
|
Dementia with lewy bodies: implications for clinical trials.
The neurobehavioral and pathologic features of Parkinson disease dementia... | 19th April, 2005
| PRA International, Ottawa, Ontario, Canada.
| Clin Neuropharmacol. 2004 Nov-Dec;27(6):281-92.
|
